Actinomycin D associated hepatic veno-occlusive disease — A report of 2 cases

References

• D'Angio GJ, NWTS Committee. Hepatotoxicity of actinomycin-D (letter). Lancet 1987; ii: 104–104
   Google Scholar
• Pritchard J, Raine J, Wallendszus K. Hepatotoxicity of actinomycin-D (letter). Lancet 1989; 1: 168–168
   PubMed Web of Science ®Google Scholar
• Morgan, E, Baum, E, Breslow, N, et al. Chemotherapy-related toxicity in infants treated according to the second national Wilms' tumour study. J Clin Oncol 1988; 6: 51–55
   PubMed Web of Science ®Google Scholar
• Cassady JR, Carabell SC, Jaffe N. Chemotherapy-irradiation related hepatic dysfunction in patients with Wilms' tumour. Front Radiat Ther Oncol 1979; 13: 147–160
   Google Scholar
• Tefft M. Radiation related toxicity in national Wilms' tumour study number 1. Int J Radiat Oncol Biol Phys 1977; 2: 455–463
   PubMed Web of Science ®Google Scholar
• McVeagh P, Ekert H. Hepatotoxicity of chemotherapy following nephrectomy and radiation therapy for right-sided Wilms' tumour. J Pediatr 1975; 87: 627–628
   PubMed Web of Science ®Google Scholar
• Jayabose S, Shende A, Lanzkowsky P. Hepatotoxicity of chemotherapy following nephrectomy and radiation therapy for right-sided Wilms' tumour (letter). J Pediatr 1976; 88: 898–898
   PubMed Web of Science ®Google Scholar
• Bjork O, Eklof O, Willi U, Ahstrom L. Veno-occlusive disease and peliosis of the liver complicating the course of Wilms' tumour. Acta Radiol Diagn 1985; 26: 589–597
   PubMedGoogle Scholar
• Jones B, Breslow NE, Takashima J. Toxic deaths in the second national Wilms' tumour study. J Clin Oncol 1984; 2: 1028–1033
   PubMed Web of Science ®Google Scholar
• Ruchelli ED, Horn M, Taylor SR. Severe chemotherapy-related hepatic toxicity associated with MZ protease inhibitor phenotype. Am J Ped Hematol Oncol 1990; 12: 351–354
   PubMedGoogle Scholar
• De Sio, L, Cozza, R, Deb, G, et al. Severe liver toxicity in pre-operative chemotherapy of SIOP9 protocol (abstract). Med Pediatr Oncol 1989; 17: 316–316
   Google Scholar
• Green, DM, Norkool, P, Breslow, NE, et al. Severe hepatic toxicity after treatment with vincristine and dactinomycin using single-dose or divided-dose schedules: a report from the National Wilms' Tumour Study. J Clin Oncol 1990; 8: 1525–1530
   PubMed Web of Science ®Google Scholar
• Raine, J, Bowman, A, Wallendszus, K, et al. Hepatopathy-thrombocytopenia syndrome-a complication of dactinomycin therapy for Wilms' tumour: a report from the United Kingdom Children's Cancer Study Group. J Clin Oncol 1991; 9: 268–273
   PubMed Web of Science ®Google Scholar
• Green, DM, Finklestein, JZ, Norkool, PN, et al. Severe hepatic toxicity after treatment with single-dose dactinomycin and vincristine: a report of the National Wilms' Tumour Study. Cancer 1988; 62: 270–273
   PubMed Web of Science ®Google Scholar
• White L, Tobias V, Hughes DW. Actinomycin D-induced hepatotoxicity. Pediatr Hematol Oncol 1989; 6: 53–57
   PubMed Web of Science ®Google Scholar
• D'Angio GJ. Chemotherapy and veno-occlusive disease of the liver [letter; comment]. Pediatr Hematol Oncol 1989; 6: 51–51
   PubMed Web of Science ®Google Scholar
• D'Angio GJ. Hepatotoxicity and actinomycin D. Lancet 1990; 1: 1290–1290
   Web of Science ®Google Scholar
• Oberlin, O, Tournade, MF, Daltroff, G, et al. Hepatic toxicity compatible with veno-occlusive disease (VOD) after actinomycin D in non-irradiated Wilms' tumour (abstract). Med Pediatr Oncol 1989; 17: 317–317
   Google Scholar
• Zoubek, A, Wiesbauer, P, Pracher, E, et al. Veno-occlusive disease of the liver as a treatment complication in children with Wilms' tumour. Paediatr Padol 1992; 27: 47–50
   PubMedGoogle Scholar
• Zimmerman HJ, Ishak KG. Hepatic injury due to drugs and toxins. Pathology of the Liver2nd edn., RNM MacSween, PP Anthony, PJ Scheuer. Churchill Livingstone, Edinburgh 1985; 503–573, In
   Google Scholar
• Aviles, A, Herrera, J, Ramos, E, et al. Hepatic injury during doxorubicin therapy. Arch Pathol Lab 1984; 108: 912–913
   PubMed Web of Science ®Google Scholar
• Costa G, Hreshchyshyn NM, Holland JF. Initial clinical studies with vincristine. Cancer Chemother Rep 1962; 24: 39–44
   PubMedGoogle Scholar
• Phillips THL, Fu KK. Quantification of combined radiation therapy and chemotherapy effects on critical normal tissues. Cancer 1976; 37: 1186–1186
   PubMed Web of Science ®Google Scholar
• Reed GB, Cox AJ. The human liver after radiation injury. A form of veno-occlusive disease. Am J Pathol 1966; 48: 597–597
   PubMed Web of Science ®Google Scholar
• Mion, F, Napoleon, B, Berger, F, et al. Azathioprine induced liver disease: nodular regenerative hyperplasia of the liver and perivenous fibrosis in a patient treated for multiple sclerosis. Gut 1991; 32: 715–717
   PubMed Web of Science ®Google Scholar
• Bras G, Jelliffe DB, Stuart KL. Veno-occlusive disease of the liver with non-portal type of cirrhosis, occurring in Jamaica. Arch Pathol 1954; 57: 285–300
   PubMedGoogle Scholar
• Tavassoli M. The role of conditioning regimens in homing of transplanted hemopoietic cells. Bone Marrow Transplantation 1992; 10(1)15–17
   PubMed Web of Science ®Google Scholar
• Anthony PP. Tumours and tumour-like lesions of the liver and biliary tract. Pathology of the Liver2nd edn., RNM MacSween, PP Anthony, PJ Scheuer. Churchill Livingstone, Edinburgh 1985; 574–645, In
   Google Scholar